Singapore markets close in 5 hours 41 minutes

Definitive Healthcare Corp. (DH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.67+0.17 (+3.09%)
At close: 04:00PM EDT
5.80 +0.13 (+2.29%)
After hours: 07:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 648.64M
Enterprise value 617.49M
Trailing P/E N/A
Forward P/E 14.86
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.48
Price/book (mrq)0.75
Enterprise value/revenue 2.41
Enterprise value/EBITDA 46.69

Trading information

Stock price history

Beta (5Y monthly) 1.41
52-week change 3-39.81%
S&P500 52-week change 328.04%
52-week high 312.45
52-week low 34.38
50-day moving average 37.20
200-day moving average 38.26

Share statistics

Avg vol (3-month) 3703.43k
Avg vol (10-day) 31.82M
Shares outstanding 5117.94M
Implied shares outstanding 6117.94M
Float 853.36M
% held by insiders 12.53%
% held by institutions 198.25%
Shares short (30 Apr 2024) 45.81M
Short ratio (30 Apr 2024) 410.59
Short % of float (30 Apr 2024) 410.71%
Short % of shares outstanding (30 Apr 2024) 44.94%
Shares short (prior month 28 Mar 2024) 47.44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -78.16%
Operating margin (ttm)-12.15%

Management effectiveness

Return on assets (ttm)-0.92%
Return on equity (ttm)-21.54%

Income statement

Revenue (ttm)255.69M
Revenue per share (ttm)2.22
Quarterly revenue growth (yoy)7.20%
Gross profit (ttm)N/A
EBITDA 22.55M
Net income avi to common (ttm)-199.84M
Diluted EPS (ttm)-1.76
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)298.86M
Total cash per share (mrq)2.53
Total debt (mrq)264.01M
Total debt/equity (mrq)22.09%
Current ratio (mrq)2.30
Book value per share (mrq)7.30

Cash flow statement

Operating cash flow (ttm)42.82M
Levered free cash flow (ttm)93.53M